Articles From: Bassett Announces Special Dividend to Baylin Technologies Subsidiary, Galtronics, Will Present Its Latest Antenna Solutions at the 2014 Canadian Wireless Trade Show


BASSETT, Va., Nov.
Sign-up for Bassett Announces Special Dividend investment picks
2014/12/4
By Scott Patterson WASHINGTON--A three-year investigation by market regulators into allegedly unfair treatment of investors by stock exchanges could result in the largest fine ever levied against a stock exchange, according to people familiar with the investigation.
Sign-up for BATS may face record SEC fine over Direct Edge's actions investment picks
http://media.marketwire.com/attachments/201304/142691_bridgbank.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165230&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Bauer Financial Awards Bridge Bank 5-Star Rating investment picks
http://media.marketwire.com/attachments/201501/83098_BAUERLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168274&ProfileId=051205&sourceType=1 EXETER, NH --
Sign-up for Bauer Hockey to Open First-Ever Retail Experiences investment picks
Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS® Femtosecond Laser Platform Canada NewsWire LAVAL, Quebec , Jan.
Sign-up for Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS® Femtosecond Laser Platform investment picks
2014/12/2
MUNICH , Dec.
Sign-up for Bausparkasse Mainz AG Uses MobileIron To Manage Field Service Apps investment picks
RALEIGH, N.C., Nov.
Sign-up for Baxano Surgical, Inc. Announces Termination of Its Nasdaq Listing investment picks
Baxter International Inc. (NYSE:BAX) announced the filing of an initial Form 10 Registration Statement with the U.S. Securities and Exchange Commission (SEC) in connection with the company’s previously announced plan to spin off its biopharmaceutical business.
Sign-up for Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin off of Biopharmaceuticals Business investment picks
The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.52 per Baxter common share.
Sign-up for Baxter Declares Quarterly Dividend investment picks
Baxter International (NYSE:BAX), will host a quarterly conference call to discuss its fourth quarter 2014 financial results on Thursday, January 29, 2015, at 7:30 a.m. Central Time.
Sign-up for Baxter International Fourth Quarter 2014 Financial Results Conference Call investment picks
Baxter International Inc. (NYSE:BAX) today announced the United States Food and Drug Administration (FDA) has approved PHOXILLUM Renal Replacement Solutions (BK4/2.5 and B22K4/0) as replacement solutions in continuous renal replacement therapy (CRRT) to correct electrolyte and acid-base imbalances, and in case of drug poisoning when CRRT is used to remove dialyzable substances.
Sign-up for Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy investment picks
Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration (FDA) for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)]. ''The evidence from our late-stage controlled trial showcases that BAX 855 could become an important new treatment option for people with hemophilia A, expanding on more than a decade of experience with ADVATE,'' said John Orloff, M.D., vice president and global head of research and development for Baxter BioScience.
Sign-up for Baxter Submits Application for U.S. FDA Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A investment picks
Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for the approval of BAX111, the first highly-purified recombinant von Willebrand Factor (rVWF) in clinical development as a treatment for patients with von Willebrand disease, the most common type of inherited bleeding disorder.
Sign-up for Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease investment picks
Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Treatment SAN FRANCISCO , Dec.
Sign-up for Baxter Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A investment picks
Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its proprietary Vero cell technology and related assets, including its production facility in Bohumil, Czech Republic, to Nanotherapeutics, Inc. Financial details were not disclosed.
Sign-up for Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics investment picks
Baxter International Inc. (NYSE: BAX) announced today that it will present at the 33 rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 5:00 p.m. (CT). The live webcast of Baxter’s presentation along with the accompanying slides can be accessed from the Baxter corporate website at www.baxter.com .
Sign-up for Baxter to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
Baxter International Inc. (NYSE: BAX) announced today that it will present at the 26 th Annual Piper Jaffray Healthcare Conference Tuesday, December 2, 2014 at 12:00 p.m. (CT). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com .
Sign-up for Baxter to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Stifel 2014 Healthcare Conference on Wednesday, November 19, 2014 at 10:30 a.m. (CT). The live webcast of Baxter’s presentation and accompanying slides can be accessed from the Baxter corporate website at www.baxter.com .
Sign-up for Baxter to Present at the Stifel 2014 Healthcare Conference investment picks
Baxter International Inc. (NYSE: BAX) has been named as one of America’s most community-minded companies by the Points of Light Foundation’s Civic 50 list, and also received recognition for its inclusion and diversity leadership by several external organizations.
Sign-up for Baxter’s Culture of Community Engagement and Inclusion Recognized by Leading Organizations investment picks
Baxter International Inc. (NYSE:BAX) presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment for primary immunodeficiencies (PI) during the biennial congress of the European Society for Immunodeficiencies, held in Prague.
Sign-up for Baxter’s Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study investment picks
2014/12/18
Cardinal Health to build 64,000 square foot, state-of-the-art facility to manufacture radioactive therapeutic agent used to treat patients with bone metastases from castration-resistant prostate cancer WHIPPANY, N.J. and DUBLIN, Ohio , Dec.
Sign-up for Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® (radium Ra 223 dichloride) Injection investment picks
2014/11/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979831001&sourceType=1 http://media3.marketwire.com/logos/20140514-BAYF.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Bayfield Announces Completion of Pre-Conditions to Advances Under the Convertible Loan with New Gold investment picks
Bayfield Ventures Shareholders Approve Plan of Arrangement with New Gold Canada NewsWire TORONTO , Dec.
Sign-up for Bayfield Ventures Shareholders Approve Plan of Arrangement with New Gold investment picks
Year-To-Date Net Income Rises 17% STURGEON BAY, Wis.
Sign-up for Baylake Corp. Announces Third Quarter, Nine Months of 2014 Financial Results investment picks
STURGEON BAY, Wis.
Sign-up for Baylake Corp. Declares Dividend investment picks
STURGEON BAY, Wis.
Sign-up for Baylake Corp. Declares Dividend investment picks
http://media.marketwire.com/attachments/201403/72521_baylin.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154221&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Baylin Technologies Subsidiary, Galtronics, Will Present Its Latest Antenna Solutions at the 2014 Canadian Wireless Trade Show investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Bassett Announces Special Dividend to Baylin Technologies Subsidiary, Galtronics, Will Present Its Latest Antenna Solutions at the 2014 Canadian Wireless Trade Show
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent